Osaic Holdings’s Moleculin Biotech MBRX Stock Holding History

Osaic Holdings’s Portfolio MBRX Stock Details MBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Hold	0	–	–	–	7976
2026 Q1	–	Hold	0	–	–	–	7780
2025 Q4	–	Hold	0	–	–	–	7797
2025 Q3	–	Hold	0	–	–	–	7826
2025 Q2	–	Hold	0	–	–	–	7676
2025 Q1	–	Hold	0	–	–	–	7302
2024 Q4	–	Hold	0	–	–	–	7261
2024 Q3	–	Hold	0	–	–	–	7281
2024 Q2	–	Hold	0	–	–	–	7265
2024 Q1	–	Hold	0	–	–	–	6871
2023 Q4	–	Hold	0	–	–	–	6811
2023 Q3	–	Hold	0	–	–	–	7029
2023 Q2	–	Hold	0	–	–	–	7024
2023 Q1	–	Hold	0	–	–	–	6979
2022 Q4	–	Sell	-1	Closed	-$8.44K	–	6799
2022 Q3	$4K	Hold	1	–	–	﹤0.01%	6493
2022 Q2	$6K	Hold	1	–	–	﹤0.01%	6392
2022 Q1	$7K	Buy	+1	New	+$11.5K	﹤0.01%	6331
2021 Q4	–	Hold	0	–	–	–	7210
2021 Q3	–	Hold	0	–	–	–	6868
2021 Q2	–	Hold	0	–	–	–	6601
2021 Q1	–	Hold	0	–	–	–	6379
2020 Q4	–	Hold	0	–	–	–	5859
2020 Q3	–	Hold	0	–	–	–	5329
2020 Q2	–	Hold	0	–	–	–	5675

Other funds holding MBRX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings's MBRX Position: Q2 2026 in Review

Osaic Holdings held its Moleculin Biotech (MBRX) position steady in Q2 2026 at 0 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7976.

Osaic Holdings first reported a position in MBRX in Q1 2022 and has held it in 3 quarters since. The position peaked at $7K in Q1 2022. 15 funds tracked by Wall St. Rank hold MBRX as of Q2 2026.

Osaic Holdings held 0 shares of Moleculin Biotech worth $2 as of Q2 2026.
Osaic Holdings left its Moleculin Biotech share count unchanged in Q2 2026.
Moleculin Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7976 holding.
Osaic Holdings first reported a position in Moleculin Biotech in Q1 2022 and has held it in 3 quarters since.
Osaic Holdings's Moleculin Biotech position peaked at $7K in Q1 2022.
15 funds tracked by Wall St. Rank held Moleculin Biotech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.